Three-dimensional type I collagen gel system containing MG-63 osteoblasts-like cells as a model for studying local bone reaction caused by metastatic cancer cells

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2773-2780

  Sourla, Antigone ^a   Doillon, Charles ^a   Koutsilieris, Michael ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Bone metastasis; Cathepsin D; Osteolysis; Osteoplasia; Urokinase type plasminogen activator

Indexed keywords

CATHEPSIN D; COLLAGEN TYPE 1; UROKINASE;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL COUNT; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIUM CANCER; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER;

BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; CATHEPSIN D; CELL COMMUNICATION; COLLAGEN; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OSTEOBLASTS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029908177     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Beliveau RE, Spencer RP: Incidence and staging of hone lesions detected by 99mTc polyphosphate scans in patients with tumors. Cancer 36: 65-72, 1975.
2. Galasko CSB: Mechanism of bone destruction in the development of skeletal metastases. Nature 263: 507-508, 1976.
3. Galasko CSB: Mechanism of lytic and blastic metastatic disease of hone. Clin Orth Rel Res 12: 20-25 , 1982.
4. Jacobs SC, Pinka D, Lawson RK: Prostatic osteoblast factor. Invest Urol 17: 195-199, 1988.
5. Koutsilieris M, Rabbani SR, Goltzman D: Selective mitogens can be extracted from prostatic tissue. Prostate 9: 109-114, 1986.
6. Koutsilieris M, Rabbani SR, Goltzman D: Effects of prostatic mitogens on rat bone cells and fibroblasts. J Endocrinol 115: 447-453, 1987a.
7. Koutsilieris M, Rabbani SR, Bennett HPJ, Goltzman D: Characterization of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Invest 80: 941-947, 1987b.
8. Perkel VS, Mohan S, Herring SJ, Baylink, DJ, Linkhart TA: Human prostatic cancer cells, PC-3, elaborate mitogenic activity which selectively stimulated human bone cells. Cancer Res 50: 6902-6907, 1990.
9. Bennett A, McDonald AM, Simpson JS: Breast cancer, prostaglandins and hone metastases. Lancet 9: 1218-1220, 1975.
10. Galasko CSB, Bennett A: Relationship of hone destruction metastases to osteoclast activation and prostaglandins. Nature 263: 508-510, 1976.
11. 3H] tetracycline excretion from prelabeled mice. J Bone Miner Res 3: 621-627, 1988.
12. Casser-Bette M, Murray AB, Closs EI, Erfle V, Schidt J: Bone formation by osteoblast-like cells in a three-dimensional cell culture. Calcif Tissue Int 46: 46-52, 1990.
13. Ponton A, Coulombe B, Skup D: Decreased expression of the tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increase levels of collagenase activity. Cancer Res 51: 2138-2143, 1991.
14. Shi YE, Torri J, Yieh L, Wellstein A, Lippman ME, Dickson RB: Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer. Cancer Res. 53: 1409-1415, 1993.
15. Westley BR, May FEB: Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucl Acids Res 15: 3771-3786, 1987.
16. Hienert G, Kirchheimer JC, Christ G, Pfluger H, Binder BR: Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinoma. Eur Urol 15: 256-258. 1988.
17. Janicke F, Schitt M, Haftert R, Hollrieder A, Babic R, Ulm K: Urokinase-type plasminogen activator (uPA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 4: 69-78, 1990.
18. Needhanm GK, Nicholson S, Angus B, Farndon JR, Harris AL: Relationship of membrane-bound tissue-type and urokinase-type plasminogen activators in human breast cancers to estrogen and epiderman growth factor receptors. Cancer Res 48: 6603-6607, 1989.
19. Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindan MV, Polychronakos C: Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 13: 481-486, 1993.
20. Koutsilieris M, Polychronakos C: Proteinolytic activity against IGF-hinding proteins involved in the paracrine interactions between prostate adenocarcinoma cells and osteoblasts. Anticancer Res 12: 905-908, 1992.
21. Polychronakos C, Janthly U, Lehoux J-G, Koutsilieris M: Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved. Prostate 9: 313-318, 1991.
22. Boulanger J, Reyes-Moreno C, Koutsilieris M: Mediation of the glucocorticoid receptor tGR) function by the activation of latent transforming growth factor beta 1 in MG63 osteoblast-like osteosarcoma cells. Int J Cancer 62: 692-697, 1995.
23. Yee JA, Yan L, Dominguez JC, Allan EH, Martin TJ: Plasminogen-dependent activation of latent transforming growth factor beta by growing cultures of osteoblast-like cells. J Cell Physiol 157: 528-534, 1993.
24. Thompson BM, Atkinson SJ, McGarrity, AM, Hembry RM, Reynolds JJ, Meikle MC: Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasminmetalloproteinase activation cascade. Biochim. Biophys. Acta 1014: 125-132, 1989.
25. Koutsilieris M: Skeletal metastasis in advanced prostate cancer:cell biology and therapy. Crit Rev Oncol Hematol 18: 51-64, 1995.
26. Shaikh MS, Shao Z-M, Clemmons DR, LeRoith D, Roberts CT, Fontana JA: Identification of the insulin-like growth factors binding proteins 5 and 6 in human breast cancer cells. Biochem Biophys Res Commun 183: 1003-1010, 1992.
27. Soules HD, Vasquez J, Long A, Albert S, Brennan MA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
28. Kaighn ME, NAarayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
29. Koutsilieris M, MICHaud-Allaire, L, Fortier M, Lemay A: Mitogen(s) for endometrial-like cells can be detected in human peritoneal fluids. Fertil & Steril 56: 888-893, 1991.
30. Masi L, Franchi A, Santucci M, Danielli D, Arganini A, Giannone V: Adhesion, growth and matrix production by osteoblasts on collagen substrata. Calcif Tissue Int 51: 202-209, 1992.
31. Storn SC, Michalopoulos G: Collagen as substrate for cell growth and differentiation. Methods Enzymol 544: 82-94, 1982.
32. Koutsilieris M, Sourla A, Pelletier G, Doillon C: Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer. J Bone Miner Res 9: 1823-1832, 1994.
33. 1. J Pathol 139: 383-389, 1983.
34. Friedman E: Tissue culture model of adenoma invasion. Semin Surg Oncol 3: 171-177, 1987.
35. Schor SL, Schor AM, Winn B, Rushton G: The use of three-dimensional collagen gels for the study of tumour cell invasion in vitro: experimental parameters influencing cell migration into the gel matrix. Int J Cancer 29: 57-63, 1982.
36. Reyes-Moreno C, Frenette G, Boulanger J, Lavergne E, Govindan MV, Koutsilieris M: Mediation of glucocorticoid receptor function by transforming growth factor beta 1 expression in human PC-3 prostate cancer cells. Prostate 26: 260-269, 1995.
37. Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1054, 1994.